The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Abstract Background Multiple therapies exist for patients with metastatic castration-resistant prostate cancer (mCRPC). However, their improvement on progression-free survival (PFS) remains modest, potentially explained by tumor molecular heterogeneity. Several prognostic molecular biomarkers have b...

Full description

Bibliographic Details
Main Authors: Alessio Crippa, Bram De Laere, Andrea Discacciati, Berit Larsson, Jason T. Connor, Erin E. Gabriel, Camilla Thellenberg, Elin Jänes, Gunilla Enblad, Anders Ullen, Marie Hjälm-Eriksson, Jan Oldenburg, Piet Ost, Johan Lindberg, Martin Eklund, Henrik Grönberg
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Clinical trial platform
Genetic biomarker
Prostate cancer
Precision medicine
Online Access:http://link.springer.com/article/10.1186/s13063-020-04515-8

Internet

http://link.springer.com/article/10.1186/s13063-020-04515-8

Similar Items